Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.53 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.53 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.53 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.53 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.53 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.53 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 5/20 | 0.49 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL318840 | 1.00 | ALDH1A1 (0.58) | ALDH1A1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL5797759 | 0.84 | ALDH1A1 (0.59) | ALDH1A1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL8184665 | 0.84 | ALDH1A1 (0.59) | ALDH1A1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL5830527 | 0.83 | AKR1C3 (0.52) | ALDH1A1MAPTTDP1MEN1KMT2A | |
| SCHEMBL5830531 | 0.83 | AKR1C3 (0.52) | ALDH1A1MAPTTDP1MEN1KMT2A | |
| SCHEMBL2567047 | 0.82 | LMNA (0.56) | ALDH1A1MAPTCA1CA2TDP1 | |
| SCHEMBL2567045 | 0.82 | LMNA (0.56) | ALDH1A1MAPTCA1CA2TDP1 | |
| SCHEMBL8136582 | 0.82 | NOS3 (0.47) | ALDH1A1MAPTTDP1LMNAKMT2A | |
| SCHEMBL7800031 | 0.82 | NOS3 (0.47) | ALDH1A1MAPTTDP1LMNAKMT2A | |
| SCHEMBL4661723 | 0.82 | ALDH1A1 (0.66) | ALDH1A1GRIN2DGRIN3BGRIN1GRIN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637440-B2 | Amide derivative useful as diacylglycerol acyltransferase 2 inhibitor, and use thereof | LG CHEM, LTD. (KR) | 2026-05-26 | — | — | US | disclosed |
| CN-114901653-B | Novel amide derivatives useful as diacylglycerol acyltransferase 2 inhibitors and uses thereof | 株式会社LG化学 | 2024-11-22 | — | — | CN | disclosed |
| EP-4074701-B1 | NOVEL AMIDE DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR, AND USE THEREOF | LG CHEMICAL LTD (KR) | 2023-12-13 | — | — | EP | disclosed |
| US-20230101389-A1 | NOVEL AMIDE DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR, AND USE THEREOF | LG CHEM, LTD. (KR) | 2023-03-30 | — | — | US | disclosed |
| EP-4074701-A1 | NOVEL AMIDE DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR, AND USE THEREOF | Lg Chem, Ltd. (KR) | 2022-10-19 | — | — | EP | disclosed |
| CN-114901653-A | Novel amide derivatives useful as diacylglycerol acyltransferase 2 inhibitors and uses thereof | 株式会社LG化学 | 2022-08-12 | — | — | CN | disclosed |
| WO-2021133038-A1 | NOVEL AMIDE DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR, AND USE THEREOF | 주식회사 엘지화학 | 2021-07-01 | — | — | WO | disclosed |
| WO-2021133038-A1 | NOVEL AMIDE DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR, AND USE THEREOF | 주식회사 엘지화학 | 2021-07-01 | — | — | WO | disclosed |
| US-10889146-B2 | Tire object provided with an elastomer layer made of a thermoplastic elastomer in the form of an (A-b-(a-methylstyrene-co-B))n-b-C block copolymer | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2021-01-12 | — | — | US | disclosed |
| US-10030131-B2 | Pneumatic object provided with a gastight layer containing a thermoplastic elastomer and a thermoplastic | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2018-07-24 | — | — | US | disclosed |
| WO-2011141466-A1 | PNEUMATIC OBJECT PROVIDED WITH A GASTIGHT LAYER CONTAININGA THERMOPLASTIC ELASTOMER AND A THERMOPLASTIC | SOCIETE DE TECHNOLOGIE MICHELIN (FR) | 2011-11-17 | — | — | WO | disclosed |
| WO-2011131560-A1 | INFLATABLE OBJECT PROVIDED WITH A GAS-TIGHT LAYER CONTAINING A THERMOPLASTIC ELASTOMER AND A HYDROCARBON-BASED RESIN | SOCIETE DE TECHNOLOGIE MICHELIN (FR) | 2011-10-27 | — | — | WO | disclosed |
| WO-2011076801-A1 | INFLATABLE ARTICLE PROVIDED WITH A GASTIGHT LAYER BASED ON A BLEND OF A THERMOPLASTIC ELASTOMER AND OF A PARTIALLY CROSSLINKED BUTYL RUBBER | SOCIETE DE TECHNOLOGIE MICHELIN (FR) | 2011-06-30 | — | — | WO | disclosed |
| WO-2011076800-A1 | PNEUMATIC OBJECT PROVIDED WITH A GAS-TIGHT LAYER COMPRISING A MIXTURE OF A THERMOPLASTIC ELASTOMER AND A BUTYL RUBBER | SOCIETE DE TECHNOLOGIE MICHELIN (FR) | 2011-06-30 | — | — | WO | disclosed |
| WO-2011009910-A1 | PNEUMATIC OBJECT PROVIDED WITH A GASTIGHT LAYER MADE OF A THERMOPLASTIC ELASTOMER AND LAMELLAR FILLER | SOCIETE DE TECHNOLOGIE MICHELIN (FR) | 2011-01-27 | — | — | WO | disclosed |
| WO-2010139700-A1 | ELASTOMER COMPOSITION MADE FROM A THERMOPLASTIC COPOLYMER, INFLATABLE OBJECT PROVIDED WITH A GAS BARRIER MADE FROM SUCH A COMPOSITION | SOCIETE DE TECHNOLOGIE MICHELIN (FR) | 2010-12-09 | — | — | WO | disclosed |
| EP-0910351-A1 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. Searle & Co. (US) | 1999-04-28 | — | — | EP | disclosed |
| EP-0907666-A1 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. Searle & Co. (US) | 1999-04-14 | — | — | EP | disclosed |
| WO-1997049736-A2 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. SEARLE AND CO. (US) | 1997-12-31 | — | — | WO | disclosed |
| WO-1997049387-A1 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. SEARLE AND CO. (US) | 1997-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230101389-A1 | NOVEL AMIDE DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR, AND USE THEREOF | DGAT2, DGAT1, MOGAT2 | ALDH1A1 696/4885GRIN2D 2594/4885GRIN3B 3401/4885 |
| US-12637440-B2 | Amide derivative useful as diacylglycerol acyltransferase 2 inhibitor, and use thereof | DGAT2, DGAT1, DLAT | ALDH1A1 885/4885GRIN2D 1619/4885GRIN3B 2668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.